AHA/ASA Issues Guidance for Optimal Stroke Care During COVID-19 Pandemic
AHA/ASA Stroke Council leadership published temporary emergency guidance for stroke management in the midst of COVID-19.
Stroke
Novel Clinical and Genetic Score Can Identify Risk for Atrial Fibrillation and Stroke
Researchers developed and validated a clinical and genetic score to identify individuals at high risk for atrial fibrillation and stroke.
Physiologic Traits Associated CPAP Adherence in Patients With Stroke and OSA
Physiologic traits that cause obstructive sleep apnea are also associated with adherence to continuous positive airway pressure in patients with stroke.
Sleep Abnormalities and Embolic Stroke of Undetermined Source
Embolic stroke of undetermined source is associated with elevated periodic limb movements and increased sleep onset latency.
Increased Risk for Major Cardiovascular Events Following Ischemic Stroke
First-ever ischemic stroke is associated with increased risk for major cardiovascular events among older adults without pre-existing cardiovascular disease.
Higher Combined oxLDL and LDL Levels Found to Be Associated With Recurrent Stroke
The combination of higher serum oxLDL and LDL levels was found to be associated with an increased risk for recurrent stroke and poor functional outcomes in patients who have had minor stroke or are at high risk for TIAs.
Statin-Associated Risk for Intracerebral Hemorrhage in Patients With Prior Stroke
Treatment with statins is not associated with increased risk for ICH in patients with a history of stroke, and may even decrease the risk for ICH in some of these patients.
Reperfusion Outcomes in Stroke Patients Treated With Idarucizumab
Treatment with idarucizumab can safely facilitate stroke thrombolysis in dabigatran-treated patients, with similar outcomes as patients who did not require idarucizumab therapy.
Use of Double Layer Stent With Proximal Cerebral Protection in CAS Offers Best Outcome
Carotid artery stenting performed with the double-layer Roadsaver stent and proximal protection using the Mo.Ma Ultra device was found to be associated with
the best outcomes, in terms of microembolic signals, in high-risk patients with lipid-rich plaques.
Vitamin K Antagonist Cessation and Stroke/TIA Risk in Newly Diagnosed Atrial Fibrillation
Discontinuation of vitamin K antagonist oral anticoagulant therapy was associated with an elevated risk for stroke or transient ischemic attack in patients newly diagnosed with nonvalvular atrial fibrillation.
Next post in Stroke
